Jascartin Tablet contains Levo-carnitine 500 mg, an essential nutrient involved in the metabolism of fatty acids and energy production within the mitochondria. It is primarily indicated for the treatment of carnitine deficiency, which may occur due to genetic disorders, chronic renal failure, or secondary to certain medications. Levo-carnitine facilitates the transport of long-chain fatty acids into the mitochondria, enhancing fatty acid oxidation and improving cellular energy metabolism. This therapeutic agent is also employed as an adjunct in managing conditions such as muscle weakness, fatigue, and cardiomyopathies associated with carnitine deficiency. Jascartin Tablet may be prescribed to patients undergoing hemodialysis to replenish depleted carnitine levels and improve overall muscle function and quality of life. The recommended dosage and duration of therapy should be determined by a healthcare professional based on the patient’s clinical condition and response to treatment. Commonly, Jascartin is well tolerated; however, some patients may experience mild gastrointestinal disturbances such as nausea or abdominal discomfort. It is contraindicated in individuals with hypersensitivity to Levo-carnitine. Caution is advised in patients with seizure disorders. Regular monitoring of clinical and biochemical parameters is recommended during therapy to assess efficacy and safety.